Co-milled API-lactose systems for inhalation therapy: impact of magnesium stearate on physico-chemical stability and aerosolization performance

References

• Gupta PK, Hickey AJ. Contemporary approaches in aerosolized drug delivery to the lung. J Control Release 1991;17:127–47.
   Web of Science ®Google Scholar
• Timsina MP, Martin GP, Marriott C, et al. Drug delivery to the respiratory tract using dry powder inhalers. Int J Pharm 1994;101:1–13.
   Web of Science ®Google Scholar
• Wetterlin K. Turbuhaler: a new powder inhaler for administration of drugs to the airways. Pharm Res 1988;5:506–8.
   PubMed Web of Science ®Google Scholar
• Smyth HDC, Hickey AJ. Carriers in drug powder delivery. Am J Drug Deliv 2005;3:117–32.
   Google Scholar
• Morton DAV, Staniforth J, Inventors; Vectura Ltd, Assignee. Dry powder composition comprising co-jet milled particles for pulmonary inhalation. WIPO, WO/2005/025536, 2005 Mar 24.
   Google Scholar
• Stank K, Steckel H. Physico-chemical characterisation of surface modified particles for inhalation. Int J Pharm 2013;448:9–18.
   PubMed Web of Science ®Google Scholar
• Steckel H, Stank K. Powder processing: performance improvements through co-milling. Respir Drug Deliv 2014;1:89–98.
   Google Scholar
• Chikhalia V, Forbes RT, Storey RA, Ticehurst M. The effect of crystal morphology and mill type on milling induced crystal disorder. Eur J Pharm Sci 2006;27:19–26.
   PubMed Web of Science ®Google Scholar
• Begat P, Young PM, Edge S, et al. The effect of mechanical processing on surface stability of pharmaceutical powders: visualization by atomic force microscopy. J Pharm Sci 2003;92:611–20.
   PubMed Web of Science ®Google Scholar
• Florence AT, Salole EG. Changes in crystallinity and solubility on comminution of digoxin and observations on spironolactone and oestradiol. J Pharm Pharmacol 1976;28:637–42.
   PubMed Web of Science ®Google Scholar
• Otsuka M, Kaneniwa N. Effect of grinding on the crystallinity and chemical stability in the solid state of cephalothin sodium. Int J Pharm 1990;62:65–73.
   Google Scholar
• Hancock BC, Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 1997;86:1–12.
   PubMed Web of Science ®Google Scholar
• Guinot S, Leveiller F. The use of MTDSC to assess the amorphous phase content of a micronized drug substance. Int J Pharm 1999;192:63–75.
   PubMed Web of Science ®Google Scholar
• Ward GH, Schultz RK. Process-induced crystallinity changes in Albuterol sulfate and its effect on powder physical stability. Pharm Res 1995;12:773–9.
   PubMed Web of Science ®Google Scholar
• Brodka-Pfeiffer K, Langguth P, Grass P, Hausler H. Influence of mechanical activation on the physical stability of salbutamol sulphate. Eur J Pharm Biopharm 2003;56:393–400.
   PubMed Web of Science ®Google Scholar
• Zografi G. States of water associated with solids. Drug Dev Ind Pharm 1988;14:1905–26.
   Web of Science ®Google Scholar
• Visser J. Van der Waals and other cohesive forces affecting powder fluidization. Powder Technol 1989;58:1–10.
   Web of Science ®Google Scholar
• Coelho MC, Harnby N. Moisture bonding in powders. Powder Technol 1978;20:201–5.
   Web of Science ®Google Scholar
• Zimon AD. Adhesion of dust and powder. New York: Springer US; 1982.
   Google Scholar
• Borgstrom L, Asking L, Lipniunas P. An in vivo and in vitro comparison of two powder inhalers following storage at hot/humid conditions. J Aerosol Med 2005;18:304–10.
   PubMedGoogle Scholar
• Li J, We Y. Lubricants in pharmaceutical solid dosage forms. Lubricants 2014;2:21–43.
   Google Scholar
• Pilcer G, Amighi K. Formulation strategy and use of excipients in pulmonary drug delivery. Int J Pharm 2010;392:1–19.
   PubMed Web of Science ®Google Scholar
• Hoppentocht M, Hagedoorn P, Frijlink HW, de Boer AH. Technological and practical challenges of dry powder inhalers and formulations. Adv Drug Deliv Rev2014;75:18–31.
   PubMed Web of Science ®Google Scholar
• Morton DAV, Inventor; Vectura Ltd, Assignee. Dry powder inhaler formulations comprising surface-modified particles with anti-adherent additives. WIPO patent, WO/2006/056812, 2005 Nov 23.
   Google Scholar
• Zhou Q, Qu L, Gengenbach T, et al. Investigation of the extent of surface coating via mechanofusion with varying additive levels and the influences on bulk powder flow properties. Int J Pharm 2011;413:36–43.
   PubMed Web of Science ®Google Scholar
• Zhou QT, Qu L, Larson I, et al. Improving aerosolization of drug powders by reducing powder intrinsic cohesion via a mechanical dry coating approach. Int J Pharm 2010;394:50–9.
   PubMed Web of Science ®Google Scholar
• Begat P, Price R, Harris H, et al. The influence of force control agents on the cohesive-adhesive balance in dry powder inhaler formulations. KONA Powder 2005;23:109–21.
   Google Scholar
• Tay T, Das S, Stewart P. Magnesium stearate increases salbutamol sulphate dispersion: what is the mechanism? Int J Pharm 2010;383:62–9.
   PubMed Web of Science ®Google Scholar
• Iida K, Hayakwawa Y, Okamoto H, et al. Influcence of storage humidity on the in vitro inhalation properties of salbutamol sulfate dry powder with surface covered lactose carrier. Chem Pharm Bull 2004;52:444–6.
   PubMed Web of Science ®Google Scholar
• Stanifoth JN, Rees JE, Lai FK, Hersey JA. Interparticulate forces in binary and ternary ordered powder mixes. J Pharm Pharmacol 1982;34:141–5.
   PubMed Web of Science ®Google Scholar
• Zhu K, Tan RBH, Ng WK, et al. Analysis of the influence of relative humidity on the moisture sorption of particles and the aerosolization process in a dry powder inhaler. J Aerosol Sci 2008;39:510–24.
   Web of Science ®Google Scholar
• Das S, Larson I, Young PM, Stewart P. Influence of storage relative humidity on the dispersion of salmeterol xinafoate powders for inhalation. J Pharm Sci 2009;98:1015–27.
   PubMed Web of Science ®Google Scholar
• Visser J. Particle adhesion and removal: a review. Part Sci Technol 1995;13:169–96.
   Web of Science ®Google Scholar
• Padmadisastra Y, Kennedy RA, Stewart PJ. Influence of carrier moisture adsorption capacity on the degree of adhesion of interactive mixtures. Int J Pharm 1994;104:R1–4.
   Web of Science ®Google Scholar
• Boerefijin R, Ning Z, Ghadiri M. Disintegration of weak lactose agglomerates for inhalation applications. Int J Pharm 1998;172:199–209.
   Web of Science ®Google Scholar
• Sheokand S, Modi SR, Bansal AK. Dynamic vapor sorption as a tool for characterization and quantification of amorphous content in predominantly crystalline materials. J Pharm Sci 2014;103:3364–76.
   PubMed Web of Science ®Google Scholar
• Callahan JC, Cleary GW, Elefant M, et al. Equilibrium moisture content of pharmaceutical excipients. Drug Dev Ind Pharm 1982;8:355–69.
   Web of Science ®Google Scholar
• Rowe RC, Sheskey PJ, Quinn ME, eds. Handbook of pharmaceutical excipients. 6th edn. London: Pharmaceutical Press; 2009.
   Google Scholar
• Sing KSW, Everett DH, Haul RAW, et al. Reporting physiosorption data for gas/solid systems with special reference to the determination of surface area and porosity. Pure Appl Chem 1985;57:603–19.
   Web of Science ®Google Scholar
• Briggner LE, Buckton G, Bystrom K, Darcy P. The use of isothermal microcalorimetry in the study of changes in crystallinity induced during the processing of powders. Int J Pharm 1994;105:125–35.
   Web of Science ®Google Scholar
• Price R, Young PM. Visualization of the crystallization of lactose from the amorphous state. J Pharm Sci 2004;93:155–64.
   PubMed Web of Science ®Google Scholar